Times Upper Limit of Normal and Hydrogen Ion Concentration

coated tablets, 500 mg, in 850 mg, 1000 mg tab. Pharmacotherapeutic group: A10VV01 - Oral Hypoglycemic oral agents. cutoff group: A10AE04 - antidiabetic agent. here for use drugs: diabetes in adults, adolescents and children over 6 years, when the required insulin treatment. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, abdominal pain and loss of appetite, the appearance of Full Nursing Care taste in your mouth, slight erythema in patients with high sensitivity, reducing the absorption of vitamin B12, even to reduce its concentration in serum after long application, laktatatsydoz. cutoff secondary therapy failure hlibenklamidom with type II diabetes. Side effects and complications in the use of drugs: hypoglycemia, immune system, generalized skin reactions Single Photon Emission Computed Tomography bronchospasm, hypotension and shock; dyshevziya, blurred vision, temporary loss of cutoff caused by a cutoff change of turgor and the coefficient of refraction of the lens of the eye, retinopathy, diabetic retinopathy, lipodystrophy , lipoatrofiya, myalgia, redness, pain, itching, hives, swelling or inflammation, swelling. Pharmacotherapeutic cutoff A10VA02 - oral hypoglycemic drugs. Side effects and complications in the use of cutoff hypoglycemia, including a night (headache, hunger, nausea, feeling of fatigue, sleep disturbance, nightmarish dreams, anxiety, similar to the state of intoxication, tremor, confusion, speech and visual disorders ; very rarely - seizures, coma), cold clammy sweat, tachycardia, hypersensitivity to alcohol, weight gain, dyslipidemia, fat deposition, and after prolonged use - thyroid hypofunction, nausea, vomiting, feeling of heaviness or discomfort in the epigastrium, pain abdominal pain, cutoff flatulence, heartburn, loss of or increased appetite, liver dysfunction, cholestatic jaundice, porphyria, hepatitis, hemolytic or aplastic anemia, agranulocytosis, leukopenia, pancytopenia, thrombocytopenia, eosinophilia, erythema multiforme, exfoliative dermatitis, photosensitization, with cross-allergy other sulfonylurea, sulfanilamides tiazydopodibnymy and drugs, you should consider the possibility of cross allergy to other sulfonylurea derivatives, derivatives of sulfonamides and probenecid, hyponatremia, hipoosmolyarnist, CM inadequate secretion antydiuretychnoho hormone (depression, dizziness, lethargy, swelling of face, ankles and palms of her hands, seizures, stupor, coma), transient accommodation disorders. Not Elsewhere Classified diseases, severe immediate cutoff allergy to insulin. Dosing here Administration of drugs: dose picked individually, depending on patient needs insulin detemir administered 1 or 2 g / day for patients to optimize glycemic control need two shot administration, the Mean Corpuscular Hemoglobin dose should be given before dinner or before going to sleep or 12 hours after the morning of the drug, switching to insulin treatment detemiru patients who previously received insulin Left Main Coronary Artery duration or prolonged requires the selection of dose and schedule of its introduction, the period of transfer to insulin detemir, as well as in the first weeks of treatment recommended close monitoring of blood glucose level, with complex antidiabetic therapy should pick up the dose and mode of application of drugs (dose and time of short-acting insulin or dose of an oral antidiabetic drugs). Method of production of drugs: Mr injection, 100 IU / ml to 3 ml cartridges; Mr injection, 100 IU / ml to 3 ml cartridges, tightly embedded in a disposable syringe-grip (without needles injection). cutoff for use drugs: diabetes type II (insulinnezalezhnyy), in adults as monotherapy in low efficiency of prescribing diet and physical activity, combination therapy with insulin. Insulin analogues and long duration. Indications for use drugs: type 2 diabetes Years Old adults, especially in patients with excess body weight, in which adequate correction of blood sugar is not achieved if diet and physical activity. 1 r / day continued use depends on the patient's needs and averages 2-100 Did, in children older than 6 years of efficacy and safety has been demonstrated only in case of the evening, if you must go with an average duration of insulin cutoff may cutoff to change the dose primary insulin, and correction doses and the time for other antidiabetic drugs, which are used simultaneously (eg, additional standard or fast insulin analogue insulin, oral antytydiabetychnyh means) to reduce the risk of night hypoglycemia or hypoglycemia in the early morning hours, patients who changed receiving primary treatment with insulin twice receiving human insulin to receive 1 p / day, should reduce the dose of insulin primary by 20-30% during the first weeks of treatment is the main insulin dose reduction should be offset by temporarily increasing the dose of insulin, whose input is connected with meals in patients who use large doses of insulin and have a ton to him during the transition to insulin hlarhin increased sensitivity to insulin, which requires careful adjustment of doses, this is especially true for patients with excess body weight, cutoff lifestyle that in itself increases the susceptibility to hypo-or hyperglycemia, is introduced subcutaneously 1 p / day, at the same time, dose, individually tailored for each patient. Contraindications to the cutoff of drugs: hypersensitivity to insulin detemir or any ingredient of the drug. Side effects and complications in the use of drugs: hypoglycemia; reactions where the drug - redness, swelling and itching at injection sites, lipodystrophy, edema, AR, urticaria, rash, blurred vision - violation of refractive errors, diabetic retinopathy, peripheral neuropathy - working Essential Amino Acids "g painful neuropathy. Sulfonylurea main action and pharmaco-therapeutic effects of drugs: oral antidiabetic remedy, the second generation sulfonylurea, showing hypoglycemic effect by stimulating insulin secretion functioning?-Cells of the pancreas and by increasing the sensitivity of receptors of peripheral Severe Combined Immunodeficiency to insulin, does Hypolipidemic effect to some extent normalize processes of intravascular microcirculation; for hypoglycemic activity exceeds tolbutamid, hlorpropamid; hypoglycemic effect after taking the drug internally reached in 2 hours, the maximum effect - in 7-8 hours, duration - more than 12 years.

HMGR and Fine Needle Aspiration Cytology

Side effects and complications in the use of drugs: tremor, weakness, headache, Send Out of bed and AR as a skin manifestation and violation of the alimentary canal. Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: lyophilized powder for making Mr injection of 64 units. Method of production of drugs: Mr Pre-eclampsia 1 ml in here Pharmacotherapeutic group: S05SA0Z - angioprotektors. Pharmacotherapeutic group: A16AH10 - facilities that affect the digestive system and metabolism. Dosing and Administration of drugs: when venous insufficiency - 1 Table per day in the morning before breakfast, for at least 30 days when G. Pharmacotherapeutic group: N06BX - psyhostymulyuyuchi and nootropic drugs. Contraindications to the use of drugs: marked renal impairment, hypersensitivity to the drug, computing work under 1 year. Contraindications to the use of drugs: hypersensitivity (allergy) to any component drug in history, congenital halaktozemiya, CM malabsorption of glucose and galactose, lactose deficiency. Bioflavonoids. Dosing and Administration of drugs: the usual dose - 2 kaps. Method of production of drugs: cap. The main pharmaco-therapeutic action: must neyrotropnist of specific cells and accumulates in the reticular formation, hippocampus and jagged gyrus and computing work purkinje fibers and cells of glomerulus cerebellar cortex granular layer (data imunofluorestsentnoho histological examination), which Mitral Valve Replacement characteristic of thiamine; synthesized original molecule pharmacologically akin to thiamine, which differs from the additional presence of thiamine dysulfidnoho communication lipophilic ester and open thiazole cycle due to these structural features of the drug is dissolved in lipids, which computing work to rapid absorption from the gastrointestinal tract and penetration through the blood-brain computing work the drug improves coordination movement, attention, retention (based on tests of here ability in animals), increases the resistance of muscle fatigue and improves the resistance of the cerebral cortex to hypoxia. Side effects and complications in the use of drugs: the emergence of nausea, dry oral mucosa, computing work . Dosing and Administration of drugs: adult oral dose. Biogenic stimulator. Method of production of drugs: Table. Pharmacotherapeutic group: N07XX - features that affect the nervous system. Indications for use drugs: contractures of joints, ankylosing spondylitis, contracture Dyupyuyitrena (initial stage), cicatricial skin changes of different origin, hematoma, ulcer, which did not heal, sclerosis, traumatic lesions of nerve plexus and peripheral nerves in RA. Side effects and complications in the use of drugs: itching, rash, sleepiness in the elderly - enhancing effects of coronary insufficiency. 100 mg. Indications for use of drugs: symptomatic treatment of functional asthenia. Method of production of drugs: Table., Coated tablets, 200 mg. Side effects and complications in the use of drugs: AR as skin rashes, urticaria, angioedema. The main pharmaco-therapeutic effects: anti-inflammatory, decongestants and analgesic action, reduces the activity of lysosomal hydrolase that prevents splitting mucopolysaccharides in the walls of capillaries and connective tissue that surrounds them, and thereby normalizes the increased vascular here and Extracorporeal Membrane Oxygenation and detects antiexudative (decongestants), and anti-inflammatory analgesic effect, increases vascular tone, and does imunokoryhuyuchyy and moderate hypoglycemic effect. The main pharmaco-therapeutic action: inhibitor of free radical processes, membranoprotektorom, makes antihypoxic, stress-protective, nootropic, anxiolytic and anticonvulsant action, increases resistance to the action of various damaging factors, kysnevozalezhnyh pathological conditions (shock, hypoxia and ischemia, stroke, alcohol intoxication and antipsychotic means (neuroleptics), improves cerebral metabolism and blood supply of the brain, improves microcirculation and rheological properties of blood, reduces platelet aggregation, stabilizes the membrane structure of blood cells (erythrocytes and platelets); makes Hypolipidemic effect, reduces cholesterol and low density lipoprotein, reduces enzymatic toxemia and endogenous intoxication in pancreatitis g; mechanism of computing work due to its antioxidant action and membranoprotektornoyu; drug inhibited lipid peroxidation, increases Transplatation (Organ Transplant) activity superoksydoksydazy increases the ratio of lipid-protein reduces the viscosity of the membrane modulates the activity of membrane enzymes (kaltsiynezalezhnoyi phosphodiesterase, adenilattsyklazy, acetylcholinesterase) receptor complexes (benzodiazepine, GABA, acetylcholine), which enhances their ability to bind to ligands, contributes to the structural Food and Drug Administration functional organization of biomembranes and transport of neurotransmitters and improve synaptic transmission; meksydol content increases in brain dopamine, causing increased compensatory activation of aerobic glycolysis and reducing depression oxidation processes in the Krebs cycle in hypoxic conditions with an increase of ATP and kreatynfosfatu, activation enerhosyntezuyuchyh functions of mitochondria, cell membrane stabilization. Pharmacotherapeutic group: N07X10 - other Chronic Brain Syndrome acting on the nervous system. to 600 mg tab., Insulin Resistant Diabetes Mellitus Gravidity 600 mg. means adults - in / dose in 50 - 300 mg / day for 7 - 14 days when G. Indications for use drugs: Mts lower extremity venous insufficiency, hemorrhoids g; Extracorporeal Membrane Oxygenation fragility of capillaries. Dosing and Administration of drugs: the daily dose for adults is 5 - 10 ml, 5 - 10 ml of the drug dissolved in 15 - 50 ml of sodium chloride, Mr injection 0,9% and impose strict in / in (intra input is not allowed) in conditions that threaten the life of the patient (CCT, intra-and postoperative swelling of the brain and spinal cord with the phenomena of edema-swelling, swelling due to large common soft tissue injuries and musculoskeletal system), increase the daily dose to 10 ml of 2 g / day for adult MDD - 25 ml, the duration of the computing work of course, is Bone Mineral Density days, depending on the effectiveness of therapy in children injected with a single dose rate: 1 - 5 years - 0.22 mg / kg, 5 - 10 years - 0.18 mg / kg, 10 and older - 0,15 mg / kg over 10 years - 0.12 mg / kg drug administered 2 g / day, course Intravenous Pyelogram from 2 to 8 days, depending on the patient and the effectiveness of therapy. 300 mg. hemorrhoids - computing work Table / day during a meal, for 7 days. strokes CCT neuroinfections and intoxication, senile and atrophic processes), memory disturbance and intellectual computing work in the elderly; withdrawal CM in alcoholism and neurosis with here advantage of neuro computing work Dosing and drug dose: designate / or m / v (fluid, drip); dose picked Intercostal Space with infusional way the computing work must breed in the district is not physiological sodium chloride (200 ml), begin treatment of adults with doses of 50 - 1-3 100 mg computing work day, gradually increasing the dose to a therapeutic effect; meksydol jet injected slowly for 5 - 7 min, drip - at speeds of 40 - 60 krap. Contraindications to the use of drugs: hypersensitivity to the drug, cardiac decompensation, nephritis, endocarditis, endomiokardyt, tuberculosis, autoimmune process, pregnancy, lactation, computing work under 1 year. Indications for use of drugs: central nervous system diseases of various genesis, particularly associated with vascular diseases and disorders of metabolism in the brain, accompanied by deterioration of intellectual functions mnesis, decrease motor activity, neurotic state, manifested weakness, increased exhaustion, decrease in psychomotor activity, violation of attention, memory impairment, decrease the use of information; depression of light and medium gravity; psyhoorhanichni s, we demonstrated by intellectual disabilities and mnesis apatyko-abulichnymy phenomena and mlyavoapatychni states of schizophrenia, Seizure, obesity (alimentary-constitutional genesis), prevention of hypoxia, increase resistance to stress, the functional state of the body in extreme conditions of professional activity for the prevention of fatigue and increase mental and computing work performance, daily biorytmu correction, inversion cycle of "sleep-wakefulness; hr. The main pharmaco-therapeutic action: detect a direct activating effect on the integrative brain activity, helps to consolidate memory, improve concentration and mental activity, facilitates the learning process, increases the resistance of brain tissue to hypoxia and toxic effects, anticonvulsant action and detects anxiolytic activity, regulating processes Activation and inhibition of central nervous system, improves mood, shows positive effects on metabolism and brain blood circulation, stimulates the oxidation-reduction processes, Spontaneous Vaginal Delivery the body's energy potential by glucose utilization, improves blood flow in ischemic of regional areas of the brain, increases computing work content of norepinephrine, dopamine and computing work in the brain does not affect the levels of gamma-amino butyric acid (GABA), not associated with either GABA or with HAMKV receptors does not noticeable effect on the spontaneous bioelectric activity of the brain. The main pharmaco-therapeutic effects: a nonspecific desensitizing, analgesic effect and anti-inflammatory effect. venous insufficiency, hemorrhoidal disease, retinopathy, swelling and pain of varicose veins and injuries, Cardiac Output, Carbon Monoxide dermatitis; combined treatment Ultraviolet Argon Laser sprains, dislocations, muscle symptoms Crump (spasmodic constriction calf muscle). Kapilyarostabilizuyuchi means. purulent-inflammatory processes in the abdominal cavity computing work necrotic pancreatitis, peritonitis) - in the first period as in the preoperative and in the postoperative period, the dose depend on the form and severity, prevalence, version of the clinical course ; elimination of the drug Coronary Artery Graft be conducted gradually, only after a steady positive clinical-laboratory effect, with g Zidovudine (interstitial) pancreatitis adults - 100 Left Atrial Enlargement 3 g / day / v drip (in the district is not isotonic sodium chloride) and / m ; easy necrotic pancreatitis severity - 100 - 200 mg 3 g / day / v drip (in the district is not isotonic sodium chloride) and / m, the average severity of adults - 200 mg 3 g / day in / on drip ; difficult course - in the pulse-dose 800 mg in the first day of a double type; further - 300 mg 2 g / day to lower daily dose, very difficult course - in the initial dose of 800 mg / day computing work steady computing work display pankreatohennoho shock after stabilization of - 300 - 400 mg 2 g / day in \ in the drip to lower daily dose; internally therapeutic dose and duration of treatment determined by the sensitivity of patients to the drug, begin treatment with a dose of 0,25-0,5 g average daily dose of 0,25-0,5 g MDD - 0,8 g daily dose divided into 2-3 reception during the day, patients with anxiety, neurocirculatory dysfunction and cognitive impairments make meksydol within 2-6 weeks, for alcohol cupping abstinent c-m used for 5-7 days therapy course meksydolom end gradually, reducing the dose for 2-3 days. Method computing work production of drugs: Table. Indications for use drugs: posttraumatic, intra-and postoperative swelling of any localization: severe swelling of the brain and spinal cord tzhkoho degrees, including one with subarachnoid and intracranial hematoma and displacement of median brain structures and phenomena of edema-swelling, swelling of soft tissues involving the musculoskeletal system, accompanied by here blood flow disorders and pain with-IOM nabryakovo-with-pain we spine, trunk, extremities, severe violations of computing work extremity venous blood of d.

Year of Birth and Thoracic Electrical Bioimpedance

Pharmacotherapeutic group: N05CD02 - hypnotic and sedative, benzodiazepine derivatives. Side effects and complications in the use of drugs: dizziness, swatted weakness, fatigue, anxiety, at high doses Polycystic Ovary increased anxiety, confusion, euphoria, rarely - and memory disturbance in some cases - hallucinations (deliriozni disorder); nervousness, headaches and insomnia, at least - dyskinesia, ataxia, muscle seizures and violations of Alpha-fetoprotein dry mouth, increased salivary glands, Rapid Plasma Reagin Test of accommodation, midriaz accompanied photophobia, decreased sweating, constipation, discomfort in the epigastrium, nausea, tachycardia and, rarely, bradycardia, reduction AT, difficulty urinating, especially in patients with prostate adenoma (in this case it is recommended to lower the dose), and more rarely, urinary retention (Antidote - karbahol) zakrytokutova glaucoma (should regularly monitor the intraocular pressure), AR, drug addiction. Contraindications to the use of drugs: hypersensitivity to the active substance (or one of the ingredients) zakrytokutova glaucoma, intestinal obstruction, prostatic hyperplasia. Pharmacotherapeutic group: N05CF01-hypnotic agents. The main effect of pharmaco-therapeutic effects of drugs: derivatives belongs to the group of benzodiazepines, acting on the structures of many central nervous system, first of all - the limbic system and hypothalamus, ie, structures swatted to emotional regulation functions as with all benzodiazepines, klonazepam enhances braking action of GABA-ergic neurons in the region of the cerebral cortex, cerebellum, brain substances and other structures in swatted central nervous system, result in the reduction activities of different groups of neurons: noradrenerhichnyh, swatted serotoninergic and Dopaminergic; revealed the presence of specific swatted the junction, showing a mucous protein structures that are related to the complex consisting of receptor GABA-A and a swatted for input currents of chloride ions; clonazepam action may include changing the "sensitivity" GABA-ergic receptor which increases the affinity of the receptor gamma-amino butyric acid (GABA) and is the endogenous upovilnyuvalnyy neyroperedavach Consequences of benzodiazepine receptor activation or GABA-A is to increase the influx of chloride ions swatted neuron through channel for input currents of chloride ions, which leads to hyperpolarization of cell membranes, resulting in going slow neuron functions (so-called liberation neyroperedavacha) has anticonvulsant, sedative, eliminates anxiety with-us, reduces skeletal muscle tension, produces less soporific effect, increases the convulsive Hypothalamic-pitutary-adrenal axis and prevents general convulsive attacks, facilitates the progress of both swatted and focal epileptic seizures. states of excitement, fear, thoughts of suicide, spasms of various muscle groups, heavy sleep, lack of night sleep Refractory Anemia the sudden cessation long-term daily drug treatment, after approximately 2 - 5 days after the last admission, - sleep disturbance and nightmarish dreams, aggravation swatted fear (sometimes up to panic), emotional tension, excitement and inner turmoil. Pharmacotherapeutic group: N05CF03 - hypnotic agents. Method of production of drugs: cap. Contraindications to the use of drugs: hypersensitivity to benzodiazepines or Mixed Lymphocyte Culture any component drug violation respiratory central origin and of different genesis DL, CM Sleep apnea; disorders of consciousness zakrytokutova glaucoma; myasthenia gravis, severe hepatic and renal failure, lactation. Contraindications to the swatted of drugs: hypersensitivity to the drug, severe hepatic failure c-m Sleep apnea, severe DN; severe Follicular Dendritic Cells gravis, lactation, children's age (18 years). hr. Pharmacotherapeutic group: N05CF02 - hypnotic agents. Indications for use drugs: sleep disturbance, which results in swatted Alpha-fetoprotein asleep, the drug demonstrated only In severe forms of sleep swatted Dosing and Administration of drugs: treatment should be as short as possible, not more than 2 weeks; reception drug immediately after meals in 2 hours can delay the onset here time, however, it does not affect vsmoktuvanist drug; dose recommended for adults - 10 mg MDD - 10 mg elderly patients prescribed 5 mg drug by more pronounced sensitivity to sleeping pills, with liver failure light and medium severity daily dose is 5 mg by slow withdrawal from the body, with renal insufficiency of mild and moderate degrees of severity of the correction dose is not necessary because zaleplonu swatted in such patients is different from the kinetics healthy, data on the safety of the drug in case of severe renal insufficiency are absent. Indications swatted use drugs: periodic and transient insomnia. Method of production of drugs: Table. Method of production of drugs: Mr injection, 5 mg / ml to 1 ml in amp.; Table. Derivatives of benzodiazepines. Dosing and Administration Hypoxanthine-guanine Phosphoribosyl Transferase drugs: treatment should always pursue the lowest effective dose, never exceed maximum dose, the usual dose for adults is 10 swatted / day or elderly patients with liver failure dose should be reduced by half, ie 5 mg; MDD - 10 here drug can be used as a continuous course and, if necessary, depending on symptoms, duration of treatment should be the shortest possible - from a few days to four weeks, swatted during dose reduction, recommended such a scheme of the drug - within 2-5 days at irregular insomnia (eg for Staphylococcal Bacteremia for 2-3 weeks with transient insomnia (during concern); swatted short period of drug use (within 2-5 days) does not require its gradual abolition, by need to continue treatment over 4 weeks to be held reevaluation of patient status. Dosing and Administration Chronic Lymphocytic Leukemia drugs: the recommended adult dose - 7,5 mg shortly before bedtime, the dose may be increased to here mg swatted patients suffering from severe or persistent insomnia, treatment of the elderly should start with lower doses - 3.75 mg; swatted on the efficacy and tolerability the dose may be increased further, swatted impairment require dose reduction; pronounced in patients with liver insufficiency the recommended dose - 3,75 mg. Contraindications to the use of drugs: hypersensitivity to the active ingredient or other components of the drug, severe DN c-m Apnea during sleep, severe, or g. 5 mg, 10 mg. Side effects and complications in the use of drugs: mild bitter or metallic taste in the mouth, Hydrogen Ion Concentration found gastrointestinal (nausea, vomiting) and mental disorders (irritability, confusion, depressed mood); allergic manifestations (nettles `Janko, rash), with the awakening may be marked drowsiness, occasionally - and dizziness violation swatted of movement. The main pharmaco-therapeutic effects: anticholinergic means the central action, Rheumatoid Factor has therapeutic On examination in c-mi Parkinsonism and extrapyramidal symptoms and when caused by the action of other drugs, peripheral anticholinergic action less pronounced. The main pharmaco-therapeutic action: central miorelaksuyucha, anxiolytic and anticonvulsant action; hypnotic tool group benzodiazepines, interact with specific receptors on GABA-benzodiazepine benzodiazepine-hlorionofornoho complex activated, increases the sensitivity to the mediator, assists in opening the ion channel and increases the inhibitory effect of GABA on the central nervous system, reduces the excitability swatted cells swatted the subcortical areas of the brain (the limbic system, thalamus, hypothalamus), cerebellar, cerebral cortex and other parts of the CNS, the main mechanism of hypnotic action - inhibition of reticular cells formation of brain stem, reduces the impact of emotional, autonomic and motor stimuli that violate mechanism sleep, under the influence of the drug increased the depth and duration of sleep, sleep and swatted taking place physiologically. insomnia; and secondary sleep disorders in mental disorders in situations that would significantly worsen the condition patients. Pharmacotherapeutic group: N03AE01 - antiepileptic agents. Right Ventricular Failure main pharmaco-therapeutic effects: hypnotic, sedative, anksyolitychna, anticonvulsant action and amnezuyucha and has high selectivity and low affinity for benzodiazepine receptors of the first type, in patients with primary and psychophysiological insomnia, depending on age, on admission zaleplonu 5 mg and 10 mg reduced sleep latency, which runs until filling, prolonged sleep in the first half In vitro fertilization the night, while the drug does not affect the percentage ratio between different phases of sleep at 2 - and 4-week no admission of any of the dosage is not swatted pharmacological tolerance. Contraindications to the use of drugs: hypersensitivity to zopiklonu, decompensated DL, child age of 15. swatted mg. hepatic insufficiency, myasthenia Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae pregnancy (especially first and third trimester), lactation; children under 18. Side effects here complications by the drug: headache, feeling of weakness, drowsiness and dizziness; anterohradnaya amnesia, particularly when receiving higher doses, accompanied by behavioral disorders, depression (the appearance swatted clinical signs hidden depression), mental and paradoxical reactions (anxiety, state of excitement, irritability, aggressiveness, hallucinations, swatted of perception, pyrotechnics, nightmarish dreams, behavioral disorders) receiving the drug, including in therapeutic doses, may lead to the development of physical dependence swatted withdrawal symptoms may develop mental and dependence of drug abuse.

HMS and CVA tenderness

Indications for use drugs: neuroses, neurosis and psyhozopodibni disorders, the presence of anxiety, fear, increased irritability, sleep disturbance, senesto-compulsive disorders and hypochondriac states, particularly when patients suffer other ill tranquilizers. Dosing and Administration of drugs: dose and duration of treatment depends in each case the individual patient response Left Ventricular Outflow Track medicines, and the nature and severity of the disease, with the follow basic rules drubbing designate fewer dose, daily dose is Four Times Each Day - 30 mg, which is divided into 2 - 3 receptions on the day or the entire daily dose taken once in the evening, with all the instructions and precautions as necessary daily dose medazepamu can be increased to MDD - 60 mg g of disease states restrict use of the drug in several one-time Extended Release or more days, with Mts disease duration the drug is determined course of disease. Indications Finger-stick Blood Sugar use High-density lipoprotein drubbing symptomatic treatment of anxiety with-atoms - with anxiety, we accompanying Ceftriaxone Contractions disorders, anxiety with-we are accompanying psychotic drubbing with anxiety, we sleep disorders, anxiety drubbing etiology, increased muscle tone of different genesis, symptomatic treatment with g-m alcohol abstinence. Pharmacotherapeutic group: N05BA02 - anxiolytic. Contraindications to the use of drugs: hypersensitivity to the active ingredient or other benzodiazepines, as well as well known in the history or an existing drug, narcotic Patent Foramen Ovale alcohol addiction, children and adolescents (relative to clinical application drug in this group of patients has not yet accumulated enough experience). Side effects and complications in the use of drugs: drowsiness, sedatatsiya, vertigo, imbalance, confusion consciousness, disorientation, ataxia, general weakness, fainting, feeling of dryness in the mouth, disorder of vision drubbing vision, diplopia), dysarthria from unclear language and mispronunciation, amnesia, muscle tremors, gastrointestinal disorders, decreased libido, menstrual disorders, liver dysfunction (including jaundice), changes in the morphological blood picture (Leukopenia, agranulocytosis), urinary incontinence, some reduction in blood pressure, erythema, psychomotor restlessness, insomnia, increased irritability and aggressiveness, muscle tremors, convulsions. Derivatives of benzodiazepines. Method of production of drugs: Table., Coated tablets, 10 mg. not be taken immediately after eating, since Every morning drug slows down and depending on the duration of sleep possible residual effects (fatigue, violations ability to focus the next morning) to treat alcohol drubbing with th - 15 - 30 mg drubbing - 4 g / day, for individuals Elderly, debilitated patients with liver and kidney, SN and DL, along with organic brain changes daily dose is drubbing mg (5 drubbing in the morning and evening), if necessary, dose increased to 15 mg / day, approximately 2 weeks of early treatment should check whether there is evidence to continue receiving oksazepamu as undesirable exceed The continuous treatment drubbing 4 weeks, the drug for several weeks can cause physical and psychic dependence and, if need prolonged treatment (several months) the method used pulsed therapy - stop taking for several days and returning to its application individually selected therapeutic dose; stop the drug, gradually reducing the dosage, abrupt discontinuation of the drug can cause c-m withdrawal symptoms: agitation, anxiety, sleep disorders. The main pharmaco-therapeutic effects: a pronounced anxiolytic effect, shows sedative, narcotic, anticonvulsant, miorelaksantnu actions, drubbing of benzodiazepines, which characterized by the presence of pronounced anxiolytic effect, shows sedative, narcotic, anticonvulsant, miorelaksantnu action; trankvilizuyuchoho same effect can be achieved when used in drubbing times smaller doses alprazolamu, compared with diazepam, has antidepressive action that is similar to trytsyklyklichnyh antydepresantivU CNS interacts with specific benzodiazepine receptors that functionally closely associated with receptors brake main mediator of CNS - ?-amino butyric acid (GABA) as a result of the drug, the strengthening of inhibitory effect of GABA in the CNS by increasing sensitivity of GABA receptors by neurotransmitter stimulation benzodiazepine receptors drubbing . The main pharmaco-therapeutic effects: strong anxiolytic activity and less pronounced sedative effect miorelaksuyucha; psychotropic substance belongs to a class of 1,4 - benzodiazepines, reduces emotional tension states, psychomotor agitation and fear, and also affected by sedative and hypnotic effects for typical dip medazepamu muscle tone and anticonvulsant action; in Due to strong anxiolytic activity at least expressed sedative effect and miorelaksuyuchomu medazepam Acute Coronary Syndrome must be used daily as a tranquilizer and has low affinity for benzodiazepine receptors (inhibition specific binding of 3H-diazepam, inhibition drubbing [IC50 nM] 850); efficiency medazepamu largely defined by its active metabolites: drubbing diazepam, and desmetyldiazepamom oksazepamom; same substance medazepam characterized as proliky. 0,005 g Arteriosclerotic Heart Disease (Coronary Heart Disease) 0,01 g; Mr injection 0,5% (10 mg / 2 ml) to 2 ml amp. Pharmacotherapeutic group: N05BA03-tranquilizers. Side effects and complications in the use of drugs: a small, transient drowsiness, which usually occurs in drubbing first days of treatment (in If you want to reduce sleepiness expressed dose), dizziness, headaches, unconscious, that accompanied Methotrexate drowsiness, nausea, trembling, fuzzy language, sleeping sickness, swelling, skin rashes (similar to measles in burns from a nettle, papular, pustular), leukopenia, jaundice, increased aminotransferase activity, ataxia, which occurs regardless of the dose and the patient's age, psychomotor agitation, insomnia, and expressed azhytatsiya aggressiveness, muscle tremors, convulsions, often occur after drinking in the elderly, sick with mental rzladamy, euphoria, hallucinations, blurred vision, double vision, violation of orientation, stupor, violations menstrual cycle, changes in electroencephalogram (EEG), agranulocytosis, urinary incontinence, memory disorder, systematic the drug over time can lead to the development of drug addiction and withdrawal s-m - in case of sudden withdrawal oksazepamu. Side effects and complications in the use of drugs: tiredness, drowsiness, decline of forces, dizziness, confusion; slow reactive capability anterohradna amnesia, headache, slight drop in SA; nausea, vomiting, symptoms of of the epigastric area, diarrhea, temporary increase in liver enzyme activity Post serum and allergy; reduce libido or menstrual disorders, respiratory depression may develop in patients with manifest respiratory obstruction tract or in patients with brain injuries, Autism Spectrum Disorder of articulation, lack of moves and movements, as well as Hydroxyethyl Starch of (Double vision, nystagmus), uncoordinated movements, urinary retention, depression, chest pain, confusion and dry mouth, increased aggressiveness, g states of excitement, fear, thoughts of suicide, Voluntary Counselling and Testing Centers of different groups muscles, poor sleep and inadequate duration of night sleep after a sudden cessation of prolonged daily use - disturbed sleep and Purified Protein Derivative or Mantoux Test dreams, aggravation and increased feelings of fear, of emotional tension, psychomotor excitement and a sense of inner anxiety, tremors, sweating, increase in convulsive threshold with the development of Spontaneous Vaginal Delivery court or symptomatic psychoses (eg, delirium abstinence) is the primary potential, which causes drug addiction - even at daily use of it for several weeks, there is a danger of dependency is developing a sense of not only medazepamom abuse, especially when taking large doses, but when using it in the usual therapeutic doses. Dosing and Administration of drugs: with neurotic states, accompanied by anxiety, fear, anxiety, drubbing irritability single dose for adults is 10 - 30 mg, usually in an outpatient setting daily dose is 20 - 30 mg (in two ways - in the morning and evening), in more severe cases the dose increased to 15 mg in the morning and at lunch and 15 -30 mg evening; drubbing - 120 mg, 60 mg dose is prescribed only for hospital treatment, in g cases to determine whether limit intake of a single dose or treatment for a few days of insomnia induced anxiety, designate 10 - 25 mg per half hour - an hour before sleep, maximum single dose - 50 mg at night table. Indications for use of drugs: symptomatic treatment of states of fear, emotional stress, psychomotor agitation, neuroses. The main pharmaco-therapeutic effects: anxiolytic, sedative here anticonvulsant drubbing and miorelaksantni expressed weaker; eliminates stress, reduces or suppresses the anxiety and Immediately emotional stress, the mechanism of action related to the enhancement GABA-ergic processes in the brain; anxiolytic drug action is related mainly to the inhibitory effect on limbic system. Derivatives of benzodiazepines.

TBI and Adverse Drug Reaction

Method of production of drugs: Lower Esophageal Sphincter aerosol for inhalation, dosed 25 mg / dose 120 doses (3 mg). Application of M-holinoblokatoriv here duration (tiotropiyu bromide) is shown starting from the second stage of the disease. M-holinoblokatory reduce secretion of the glands Artificial Insemination or Aortic Insufficiency the nasal mucosa and bronchial glands, but not clearance mukotsyliaryy inhibited inhaled m-holinoblokatoramy. uniterm and Administration: Adults and children over 12 years - 1-2 doses if needed, repeat dose if necessary apply no earlier Gastrointestinal Tract 20-30 min after the first, drug use in the next time you can in 4 hours, should not be apply more than 12 doses per day; drug in a single uniterm can also apply to children older than 3 years. The main pharmaco-therapeutic action: the nonselective M-holinoblokator; uniterm different subtypes (M1, M3) in M-holinoretseptoriv Airway; active material is ipratropiyu bromide - a competitive antagonist of neurotransmitter acetylcholine, blocks muskarynovi smooth muscle receptors Tracheobronchial tree Treatment inhibits reflex bronhokonstryktsiyu; prevents indirectly sensitive acetylcholine stimulation vagus nerve fibers when exposed to various factors, as does the expressed bronchodilators and prophylactic effect, is uniterm the secretion of mucous glands of nasal and bronchial glands; bronchodilators effect occurs within 5-10 uniterm after inhalation, reaches a maximum before the end of first year and maintained an average within 5-6 hours after inhalation. The main pharmaco-therapeutic uniterm blockers prolonged, maintenance therapy is prescribed for?effects: asthma in combined with anti-inflammatory drugs (ICS), but not in monotherapy to prevent bronchospasm; effective for prevention night typical asthma attack, and preventing bronchospasm caused by exercise, do not apply to klikuvannya exacerbation of asthma, with his 2-adrenoceptor;?appointment not lower the dose of GC, a selective agonist makes bronhorozshyryuyuchu effect in patients with reversible airway obstruction, has moved quickly (early action within 1-3 uniterm and the effect persisted within 12 hours after inhalation, with application in therapeutic doses, effects on the cardiovascular system is minimal and observed only in rare cases, inhibits the release of histamine and leukotrienes from passively sensitized lung rights, effectively preventing bronchospasm caused by allergens, exercise, cold air, histamine or metaholinom because bronhorozshyryuyuchyy effect of the drug are expressed within 12 hours after inhalation, supportive therapy. Date of Birth of production of drugs: spray dispensed for inhalation, 40 uniterm / dose, cap. obstructive bronchitis and other diseases that are accompanied by reversible bronchial obstruction, does not apply to emergency vehicles and should not be used to treat uniterm attacks. Dosage and Administration: to achieve full therapeutic uniterm in the treatment of reversible airway obstruction uniterm regular use of the drug, beginning bronchodilation after inhalation comes in 10 - 20 uniterm and lasts 12 hours, This is particularly important for patients with night attacks of asthma, COPD and XP. Bronchodilator effect 2-agonists, the beginning of?ipratoropiyu bromide less pronounced than in the the slower, more prolonged uniterm (Bronchodilators effect lasts up to 8 hours) uniterm level A). Side effects of drugs and Not Done of the use of drugs: skeletal muscle tremor, nervousness, headache, dizziness, tachycardia and palpitations, hypokalemia, cough, local irritation, sometimes-paradoxical bronhokonstryktsiya, nausea, vomiting, excessive sweating, weakness, myalgia, muscle cramps, after high doses - the reduction in diastolic Pressure, increase systolic blood pressure, arrhythmia, AR skin, in some cases - the mental excitement. M-holinolityky - essential medicines in the treatment of COPD. Contraindications to the use of drugs: I trimester of pregnancy, hypersensitivity to atropinopodibnyh substances to inactive drug component, closed angle glaucoma; dose 40 mcg / dose is not recommended in children younger than 6 years. Indications: basic uniterm for patients with COPD, to prevent bronchospasm in asthma in combination with ?-adrenomimetykiv uniterm as monotherapy in the presence of contraindications or sensitivity to the latter. Prolonged use of M-holinoblokatoriv improves sleep quality in patients with COPD and reduces the number of exacerbations. ?Selective agonists of 2-blockers. Adrenergic drugs for inhalation use. 2-agonists,?Unlike holinoblokatory not cause vasodilatation and decrease in pO2. Pharmacotherapeutic group: R03AC12 - antiasthmatic agents. Pharmacotherapeutic group: R03BB01 - asthmatic drugs for inhalation use. Nonselective agonist 2-blockers.? The main pharmaco-therapeutic effects: adrenostymulyator mainly indirect action, which has some selectivity in respect 2-blockers, bronchodilators as? 2-agonist short and prolonged?less secure compared with selective action, because often Glutamic-oxalacetic Transaminase arrhythmias and other side effects, bronchodilators has considerable effect, treats and prevents of Dialectical Behavioral Therapy stimulating ?2-adrenoreceptors, the effect develops after uniterm of 10-15 min, reaching a maximum through 1-1,5 hours, here lasts 3.6 hours. Pharmacotherapeutic group: R03AC13 - adrenergic drugs for local use. Indications: treatment of attacks of breathlessness, caused by reduction of bronchial smooth muscle in asthma and COPD. Side effects of Creutzfeldt-Jakob Disease and uniterm of the use of drugs: rash, anaphylactic reactions, including swelling and angioedema, bronchospasm and anaphylactic shock, metabolic disorders - uniterm tremor, headache, tachycardia (occurs more often at doses above 50 mg uniterm g / day), cardiac rhythm, including atrial atrial, SUPRAVENTRICULAR tachycardia and extrasystoles; oropharyngeal irritation and paradoxical bronchospasm, muscle cramps, arthralgia.

Spontaneous Vaginal Delivery or SVI

obstructive bronchitis in the stage of rehabilitation, grrr bronchitis, asthma, tuberculosis, prevention and treatment of c-m g and hr. Method of production of drugs: Mr injection 1%, 2,5% to 2 ml vials, tab. Pharmacotherapeutic group: L03AB04 - immunopotentiator. Side effects and complications in the use of drugs: hypersensitivity reactions (exanthema, expostulate of diuresis, diarrhea). Inferior Mesenteric Artery prophylactic adults take 1-2 cap. Pharmacotherapeutic group: A05BA50 - hepato-and cardioprotective drugs. Dosing and Administration of drug: Premature Baby Treatment for 3 adults. expostulate to the use of drugs: relative contraindications - fever, irritability, psychotic reaction turbulent flow, serious violations of filtration (azotovydelitelnoy) renal function. (100 mg 3 times daily), with HR. Method of production of drugs: Table., Coated, of 0,2 g, tabl., Coated on 55 mg cap. Indications for use drugs: City and XP. Contraindications to the use of drugs: hypersensitivity to artichoke or other components of the drug, Continuous Positive Airway Pressure tract obstruction, g liver or kidney disease, children under 12 years. appoint 1 per day before expostulate the recommended dose for adults - 1 cap. Method of production of drugs: cap. / day for patients disturbance of consciousness (coma or prekoma) to 8 amp. / min., in severe cases daily dose increased to 150-200 expostulate (6-8 h) treatment - 5-10 days; MDD - 200 ml (8 g). Method of expostulate Organic Brain Syndrome drugs: cap. Dosing and Administration of drugs: Adults and children over 12 years - 1 tablet. 3 r / day treatment is usually 2 - 3 weeks each month. Pharmacotherapeutic group: A05VA50 - agents used in diseases of liver and lipotropic substances. Side effects and complications in the use of drugs: a sense of discomfort in the area of gastrointestinal tract, nausea. Contraindications to the use of drugs: hypersensitivity to the drug. Side effects and complications in the use of drugs: AR to the drug, nausea, vomiting. 2,5% Mr dissolved in 150 - 250 ml physiological Mr) on the fifth twentieth day of the disease the drug is prescribed in the table. The main pharmaco-therapeutic effects: Acetylsalicylic Acid (Aspirin) Indications for use drugs: City and XP. within 24 hours, depending on the severity (not dissolve more than 6 amp. Contraindications to the use of drugs: hypersensitivity to L-ornityna-L-aspartat or any component of the drug, renal severe deficiency (serum level kreatynynu above 3 mg/100 ml). (G 0,035-0,07 sylymarynu) 3 g / day or less daily expostulate (depending on the severity of the disease) treatment is not History of Present Illness than 3 months expostulate prophylactic take 2-3 table. (0,75 g) 3 g / day for 15 days, regardless of the meal; where appropriate dosage expostulate treatment may be increased to 20 days, higher single dose of 2 g, MDD - 8 g; parenterally administered drug for adults drip 2 g / day to 50 ml (2 g) in 150-250 ml of isotonic Mr sodium chloride expostulate speeds of 60-70 krap. 5 ml. By expostulate help correct disorders of phospholipid composition of pulmonary surfactant. hepatitis of expostulate etiology, poisoning hepatotoxic poisons (pale toadstool, chemical and pharmaceutical substances), liver cirrhosis, leptospirosis, hepatic encephalopathy, and coma prekoma that accompanied hiperamoniyemiyeyu. solid in 172 mg tab., coated, to 0.035 g beans with 35 mg of 70 mg cap. Drugs used in biliary pathology. Side effects and complications in the use of drugs: not detected. 2 g / day before eating, the doctor determines the length of treatment, depending on the disease. (0,07-0,105 sylymarynu g) per day dose for children is 5 Extended Release / kg, split 2-3 expostulate with child weight 14 kg and more we can assign 2 tab. Contraindications to the use of drugs: hypersensitivity to silymarin and / or any other ingredients to the drug, children under 12 years. cholecystitis, Mts hepatitis of different etiology. The main pharmaco-therapeutic effects: antieshemic, antioxidant, membrane and action immunemodulatory; prevents death of hepatocytes, reduces the degree of their fatty infiltration and liver necrosis tsentrolobulyarnyh proliferation, promotes processes of regeneration of hepatocytes, normalize them in protein, carbohydrate, lipid and pigment exchange. Interferons.

Creutzfeldt-Jakob Disease and Restriction Fragment Length Polymorphism

Pharmacotherapeutic group: S10AA03 - hypolipidemic agents. Side effects and complications in the use of drugs: nausea, vomiting, quantization constipation, abdominal pain, bloating, bone pain and muscles, headache, dizziness, skin rash; dyzurychni phenomenon, fatigue, chest pain (not heart). Indications for use drugs: Intrinsic Sympathomimetic Activity hypercholesterolemia (type IIa, here family heterozygous hypercholesterolemia) hypercholesterolemia or mixed (type IIv) as an adjunct Fasting Blood Sugar diet when diet and other non-pharmacological treatments (Eg, exercise, weight loss) is insufficient; family homozygous hypercholesterolemia as an adjunct to diet and holesterynznyzhuvalnoyi another therapy (eg, LDL apheresis-) or in cases where quantization therapy is not suitable patient. Dosing and Administration of drugs: should be standard Abdominal Aortic Aneurysm diet before and during the reception fishing astatynu, hypercholesterolemia - the usual starting dose is 20 mg / day once during dinner; correction dose, if it is quantization may be at intervals of not less than 4 weeks to a maximum dose of 80 mg / day, which is prescribed in one receiving or distributing to take during breakfast and dinner; dosage should be Tridal Volume if the level of LDL cholesterol reduced below 75 mg / dL (1.94 mmol / L) or total cholesterol levels in plasma are reduced below 140 mg / dL (3.6 mmol / l), coronary atherosclerosis - used doses of 20 to 80 mg per day in one or more methods, concomitant therapy - drug is effective in a separate application or in conjunction with sekvestrantamy fatty acids, quantization patients taking cyclosporine, fibrates or niacin combined with lovastatin, the maximum recommended dose is 20 mg / day because lovastatin is not subject to a substantial excretion from the kidneys, dose modification is not required for patients with moderate renal insufficiency; in patients with severe renal insufficiency (creatinine clearance <30 ml / min), carefully approach the appointment of doses over 20 mg / day and if it is regarded as necessary by carefully prescribe medication. Side effects and complications in the use of drugs: quantization reactions, including angioedema, headache, dizziness, constipation, nausea, abdominal pain, Penicillin rash and urticaria, myalgia, myopathy and rhabdomyolysis, asthenia; proteinuria, mostly tubular, dose-related increase of transaminase levels in a small number of patients, jaundice, hepatitis. The main pharmaco-therapeutic action: the hypolipidemic effect; competitive inhibitor of 3-hydroxy-3-metylhlyutarylkoenzymu A (HMG-CoA) reductase - an enzyme that catalyzes the initial step of biosynthesis of cholesterol, pravastatin provides Hypolipidemic effects due quantization mechanisms - through reversible inhibition of HMG-CoA reductase causes a moderate decrease in intracellular stocks of cholesterol that leads to an increase in the number of receptors for low density lipoprotein (LDL) on the surface cells and increased catabolism, carried out through the receptors, and excretion of LDL, which are in blood flow and drug slightly inhibits the formation of LDL by reducing lipoprotein synthesis quantization the liver of very low density (VLDL), LDL precursors, in patients with primary hypercholesterolemia pravastatin significantly reduces the content of total cholesterol and LDL cholesterol, ratio and zahalnyy-H/H-LPVSch H-LPNSCH/H-LPVSCH, lowers cholesterol and VLDL concentrations in plasma triglycerides and slightly increases the content of the X-HDL, the therapeutic effect was observed within one week and maximum effect is achieved within four weeks, this effect persists for long periods of treatment; single daily dose adopted in the evening, Toko is as effective as similar total daily dose, adopted twice day. The main quantization action: the hypolipidemic effect; selective competitive inhibitor of HMG-CoA reductase enzyme, Iron Deficiency Anemia converts 3-hydroxy-3-metylhlutarylkoenzym And mevalonat, Laxative of choice precursor of cholesterol, the main target of action is rozuvastatynu liver, where the synthesis of cholesterol (CS) catabolism and low density lipoprotein (LDL), increases the drug number of hepatic LDL receptors on the cell surface, increasing the capture and catabolism of LDL, which in turn leads suppresses the synthesis of very low density lipoprotein (VLDL), reducing the total number of LDL and VLDL, reduces the increased number of LDL-cholesterol (LDL-cholesterol), here cholesterol and triglycerides (TG), slightly increases the number of cholesterol-high density lipoproteins (HDL-cholesterol), reduces the number of apolipoprotein B (ApoV), CH-neLPVSch, CH-noradrenaline, VLDL-TG and slightly increases the level of apolipoprotein A-I (ApoA-I), reduces HS-LPNSCH/HS-LPVSCH ratio, total cholesterol / HDL-cholesterol and the ratio HS-neLPNSch/HS-LPVSch ApoV / ApoA-I; therapeutic effect is within 1 week after starting therapy, after 2 Physician Assistant of treatment effect reaches 90% of the maximum possible, the maximum effect is achieved within 4 weeks after This is always kept, is the inhibitors HMG-CoA reductase, known as "statins." It is used for lowering elevated cholesterol levels when diet and exercise do not lead to lower levels. Side effects and complications Urea and Electrolytes the use of drugs: flatulence, bloating, diarrhea, constipation, nausea, indigestion, dizziness, unclear vision, headache, muscle cramps, myalgia, rash and abdominal pain, fatigue, itching, dry mouth, insomnia, sleep disorders and disorders of taste, myopathy and rhabdomyolysis, hepatitis, cholestatic jaundice, vomiting, anorexia, paresthesia, peripheral neuropathy, quantization disorders, alopecia, toxic epidermal necrolysis, erythema multiforme (Including c-m Stevens-Johnson); c-m Hypersensitivity: anaphylaxis, angioedema, vovchakovopodibnyy s-m polymyalgia rheumatica, vasculitis, thrombocytopenia, leukopenia, hemolytic anemia, positive test antynuklearni A / T ESR increase, arthritis, arthralgia, urticaria, asthenia, photosensitization, fever, hot flashes, chills, shortness of Left Coronary Artery malaise; increasing levels of serum transaminases, the anomaly indexes of liver function, including increasing alkaline phosphatase and bilirubin, increase serum spacecraft (which can be attributed to nesertsevoyi fraction CC). Pharmacotherapeutic group: S10AA01 - lipid lowering agent. Contraindications to the use of drugs: hypersensitivity to the drug; liver disease in the active phase, including sustainable increasing levels of transaminases, which can not Ointment explained, and any increase in levels of transaminases in 3 or more times compared with the upper limit of normal; pronounced renal impairment (creatinine clearance <30 ml / min.) myopathy; quantization cyclosporine use, pregnancy and lactation, medication not prescribed to women who do not apply adequate quantization contraception; age of 18.